Dr. David Wolff Goldfarb, MD

Dr. Goldfarb practices at HMU Surgical Center in Houston, Texas.

Dr. Goldfarb's NPI, 1225265168, was assigned on June 18, 2009. Dr. Goldfarb graduated from Baylor College Of Medicine in 2007. Dr. Goldfarb holds Texas license P4958.

Dr. Goldfarb's primary practice is HMU Surgical Center, at 4219 Richmond Ave, Suite 100, Houston, TX 77027. The practice phone is (713) 634-4433.

Dr. Goldfarb's primary practice is HMU Surgical Center in Houston, Texas. Dr. Goldfarb is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Metro Urology. Dmand AI also links Dr. Goldfarb to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldfarb practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Goldfarb's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Goldfarb is board certified in urology by the American Board of Urology. Dr. Goldfarb is licensed in Texas.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Goldfarb treats.

CMS data shows 10,462 Medicare services from Dr. Goldfarb across 36 procedure codes in 2024, for 1,279 Medicare patients. Medicare paid $428,395 for them.

CMS counts 1,279 Medicare patients who saw Dr. Goldfarb in 2024. The largest group is 65 to 74, with 691 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goldfarb's median patient age at 67, with 10% women.

In 2024, Dr. Goldfarb wrote 6,070 Medicare Part D claims for 1,218 patients. 77% of them were for generic drugs. CMS names the drug for 5,857 of them, across 43 drugs with 11 or more claims each, at $1,028,168 in total drug cost. In 2023, CMS named 4,567 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Goldfarb for performance year 2024, reported as part of a group. Dr. Goldfarb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goldfarb as offering telehealth. CMS counts 20 procedures of prostate resection by Dr. Goldfarb, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Goldfarb, published from 2011 to 2021. The most frequent topics are Clinical Competence, Equipment Design and Robotics. Dr. Goldfarb's most frequent co-authors are Brian J. Miles, MD, Niraj Badhiwala, MD and Alvin C. Goh, MD.

CMS Open Payments shows 921 general payments to Dr. Goldfarb from 78 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Intuitive Surgical, Inc. paid the most, $12,142.

Dr. Goldfarb graduated from Baylor College Of Medicine in 2007.

Dr. Goldfarb is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.